NuCana (NCNA) Other Non-Current Assets (2021 - 2023)
NuCana (NCNA) reported Other Non-Current Assets of $3.2 million for Q2 2023, down 0.94% on a YoY basis from $3.3 million in Q2 2022, and up 0.55% sequentially from $3.2 million in Q1 2023.
NuCana (NCNA) Other Non-Current Assets (2021 - 2023) Analysis & Trends
NuCana (NCNA) has 3 years of Other Non-Current Assets data on file, last reported at $3.2 million in Q2 2023.
- For the quarter ending Q2 2023, Other Non-Current Assets fell 0.94% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2023 stood at $3.2 million (down 0.94% YoY), and the FY2022 full-year result was $3.3 million, down 4.95% from the prior year.
- Other Non-Current Assets climbed to $3.2 million in Q2 2023, from $3.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.6 million in Q3 2021 to a low of $3.1 million in Q3 2022.
- A 3-year average of $3.3 million and a median of $3.3 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets fell 12.7% in 2022 and dropped 0.94% in 2023, its largest moves.
- Tracing NCNA's Other Non-Current Assets over 3 years: stood at $3.4 million in 2021, then fell by 8.06% to $3.1 million in 2022, then climbed by 3.19% to $3.2 million in 2023.
- Business Quant data shows NCNA's Other Non-Current Assets at $3.2 million in Q2 2023, $3.2 million in Q1 2023, and $3.1 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 63.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.25 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | 3.58 Mn |